Ghent University Academic Bibliography

Advanced

Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma

D Sebag-Montefiore, H Rutten, E Rullier, Marc Peeters UGent, G Brown, E Van Cutsem, S Ricci, C Van de Velde, P Quirke and R Glynne-Jones (2009)
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
pages
1 pages
conference name
2009 Gastrointestinal Cancers Symposium
conference location
San Francisco
conference start
2009-01-15
conference end
2009-01-19
language
English
UGent publication?
yes
classification
C3
id
687321
handle
http://hdl.handle.net/1854/LU-687321
date created
2009-06-10 10:55:46
date last changed
2016-12-19 15:35:06
@inproceedings{687321,
  author       = {Sebag-Montefiore, D and Rutten, H and Rullier, E and Peeters, Marc and Brown, G and Van Cutsem, E and Ricci, S and Van de Velde, C and Quirke, P and Glynne-Jones, R},
  language     = {eng},
  location     = {San Francisco},
  pages        = {1},
  title        = {Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma},
  year         = {2009},
}

Chicago
Sebag-Montefiore, D, H Rutten, E Rullier, Marc Peeters, G Brown, E Van Cutsem, S Ricci, C Van de Velde, P Quirke, and R Glynne-Jones. 2009. “Three-year Survival Result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) Study After Post-operative Chemotherapy in Patients with Locally Advanced Rectal Adenocarcinoma.” In .
APA
Sebag-Montefiore, D., Rutten, H., Rullier, E., Peeters, M., Brown, G., Van Cutsem, E., Ricci, S., et al. (2009). Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma. Presented at the 2009 Gastrointestinal Cancers Symposium.
Vancouver
1.
Sebag-Montefiore D, Rutten H, Rullier E, Peeters M, Brown G, Van Cutsem E, et al. Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma. 2009.
MLA
Sebag-Montefiore, D, H Rutten, E Rullier, et al. “Three-year Survival Result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) Study After Post-operative Chemotherapy in Patients with Locally Advanced Rectal Adenocarcinoma.” 2009. Print.